Trademark Search in Canada

AKERO

View On IC.GC.CA

REGISTERED

on 6 Jul 2022

Last Applicant/ Owned by

AKERO THERAPEUTICS INC.

840 Memorial Drive, 10th FloorCambridge, MA 02139

Serial Number

1924701 filed on 11^th Oct 2018

Registration Number

TMA1133491 registered on 6^th Jul 2022

Registration expiry Date

6^th Jul 2032

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

AKERO

Trademark usage description

pharmaceutical preparations, namely, compounds for use in the treatment of non-alcoholic steatohepatitis (nash), fibrosis, inflammatory bowel and conn Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, compounds for use in the treatment of non-alcoholic steatohepatitis (NASH), fibrosis, inflammatory bowel and connective tissue diseases, autoimmune disorders, cirrhosis, metabolic diseases, namely, diabetes, hypoglycemia, gout, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis, heart fibrosis, retinal and neurodegenerative diseases and disorders, namely, Alzheimer's, Huntington's disease, multiple sclerosis, myasthenia gravis, cerebral palsy, brain injury, spinal cord injury, and seizure disorders; Pharmaceutical preparations for the treatment of liver diseases and disorders, namely, fatty liver diseases, Steatohepatitis, hepatitis, cirrhosis, chronic liver disease, liver cancer, hemochromatosis, and Wilson disease.

Classification kind code

Class [042]
Research and development of pharmaceuticals; clinical studies

Classification kind code

Mark Details

Serial Number

1924701

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 30^th Mar 2022	Registration Pending
Submitted for opposition 191 on 30^th Mar 2022	Registration Fee Notice Sent
Submitted for opposition 42 on 12^th Jan 2022	Advertised
Submitted for opposition 26 on 16^th Dec 2021	Approved
Submitted for opposition 27 on 16^th Dec 2021	Approval Notice Sent
Submitted for opposition 22 on 19^th Mar 2021	Search Recorded
Submitted for opposition 20 on 19^th Mar 2021	Examiner's First Report
Submitted for opposition 31 on 16^th Oct 2018	Formalized
Submitted for opposition 1 on 12^th Oct 2018	Created
Submitted for opposition 30 on 11^th Oct 2018	Filed

AKERO

Classification Information

Classification kind code

Class [042]Research and development of pharmaceuticals; clinical studies

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Research and development of pharmaceuticals; clinical studies